Providing fractional CFO advice to Cannabis Innovation Center.

Flow Partners provided internal valuation guidance to Cannabis Innovation Center, a medical cannabis group at the frontier of multiple cannabis-based therapies.

Tel Aviv, Israel
·20 August 2021

Overview

Management of CIC required an actionable valuation service in order to accurately position the business in the upcoming capital raising discussions.

We have provided an independent valuation opinion that included deep dive on medical cannabis space, development pipeline analysis, risk-adjusted NPV (rNPV), comparable environment analysis, operational benchmarking, green/red flag analysis and more.

This transaction continues Flow's successful track record of advising in the digital health sector, having also advised and valued companies like Cannadorf (medical cannabis), Code Pharma, BiomX (biotechnology) or AVE & YOU (personalized skincare).

About Cannabis Innovation Center

Cannabis Innovation Center is a biotechnology group specializing in pharmaceutical medical cannabis. The group's portfolio includes brands like Stero, CannaLean, CannaMore, Cannadu and BioSeed.

About Flow Partners

Flow Partners provides founder-friendly corporate finance and fractional CFO advice to technology entrepreneurs globally. Flow was founded in 2020 and operates globally with presence in London, Berlin, Warsaw and Miami.

For more information, please visit flowpartners.io.

Enquires

For all enquiries please contact the team at hi@flowpartners.io

More clients we've worked with

Fractional CFO

Stages

Countries

Cities

Sectors

© 2026 Flow Partners (London) Ltd. All rights reserved. Registered as a limited liability company in England and Wales (registered number 12969521).

Providing fractional CFO advice to Cannabis Innovation Center. | Flow Partners